DK145283C - Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen - Google Patents

Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen

Info

Publication number
DK145283C
DK145283C DK206975A DK206975A DK145283C DK 145283 C DK145283 C DK 145283C DK 206975 A DK206975 A DK 206975A DK 206975 A DK206975 A DK 206975A DK 145283 C DK145283 C DK 145283C
Authority
DK
Denmark
Prior art keywords
vaccine
preparing
procedure
preventing pregnancy
pregnancy
Prior art date
Application number
DK206975A
Other languages
English (en)
Other versions
DK145283B (da
DK206975A (da
Inventor
G P Talwar
Original Assignee
All India Inst Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med filed Critical All India Inst Med
Publication of DK206975A publication Critical patent/DK206975A/da
Publication of DK145283B publication Critical patent/DK145283B/da
Application granted granted Critical
Publication of DK145283C publication Critical patent/DK145283C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK206975A 1975-01-28 1975-05-12 Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen DK145283C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54467775A 1975-01-28 1975-01-28
US54467775 1975-01-28

Publications (3)

Publication Number Publication Date
DK206975A DK206975A (da) 1976-07-29
DK145283B DK145283B (da) 1982-10-25
DK145283C true DK145283C (da) 1983-05-16

Family

ID=24173127

Family Applications (1)

Application Number Title Priority Date Filing Date
DK206975A DK145283C (da) 1975-01-28 1975-05-12 Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen

Country Status (11)

Country Link
US (1) US4161519A (da)
AR (1) AR217615A1 (da)
CA (1) CA1054937A (da)
CH (1) CH614626A5 (da)
DE (1) DE2518546A1 (da)
DK (1) DK145283C (da)
FI (1) FI54997C (da)
IL (1) IL47177A (da)
NL (1) NL7505412A (da)
NO (1) NO145083C (da)
SE (2) SE432526B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143305A (en) * 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US6039948A (en) * 1973-05-07 2000-03-21 The Ohio State University Method for treatment of antigenically modified polypeptides
US4762913A (en) * 1973-05-07 1988-08-09 The Ohio State University Antigenic modification of polypeptides
US6096318A (en) * 1973-05-07 2000-08-01 The Ohio State University Antigenically modified HCG polypeptides
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US5698201A (en) * 1973-05-07 1997-12-16 The Ohio State University Method for treatment of antigenically modified polypeptides
US4313871A (en) * 1978-02-06 1982-02-02 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4268435A (en) * 1979-02-06 1981-05-19 Research Corporation Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4966888A (en) * 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US5817753A (en) 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4855285A (en) * 1985-12-04 1989-08-08 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5762931A (en) * 1992-12-31 1998-06-09 National Institute Of Immunology Anti-cancer utility of HCG vaccines
WO1996015807A1 (en) * 1994-11-21 1996-05-30 Scofield Virginia L Sperm as vaccine vectors
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6716428B1 (en) 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
NZ533587A (en) * 2001-11-16 2005-11-25 Pharmexa As Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts
US20030185845A1 (en) * 2001-11-16 2003-10-02 Steen Klysner Novel immunogenic mimetics of multimer proteins
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
EP1563074B1 (en) 2002-11-12 2018-01-10 VAXum, LLC. Adenoviral vector vaccine
NZ543976A (en) 2003-05-09 2008-04-30 Pharmexa As Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
US8299229B2 (en) 2003-11-24 2012-10-30 Microvax, Llc Mucin antigen vaccine
US8828957B2 (en) * 2003-12-11 2014-09-09 Microvax, Llc Methods for generating immunity to antigen
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
US9533036B2 (en) * 2005-11-07 2017-01-03 Microvax, Llc Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
SE7505411L (sv) 1976-07-29
FI54997B (fi) 1979-01-31
AR217615A1 (es) 1980-04-15
NL7505412A (nl) 1976-07-30
FI54997C (fi) 1979-05-10
SE432706B (sv) 1984-04-16
NO751680L (da) 1976-07-29
IL47177A (en) 1979-01-31
FI751746A (da) 1976-07-29
DK145283B (da) 1982-10-25
IL47177A0 (en) 1975-06-25
CA1054937A (en) 1979-05-22
SE7807571L (sv) 1978-07-05
DE2518546A1 (de) 1976-07-29
NO145083C (no) 1982-01-27
US4161519A (en) 1979-07-17
NO145083B (no) 1981-10-05
SE432526B (sv) 1984-04-09
DK206975A (da) 1976-07-29
CH614626A5 (da) 1979-12-14

Similar Documents

Publication Publication Date Title
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
DK47476A (da) Benzoylureido-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
DK421879A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK421979A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK201975A (da) Fremgangsmade til fremstilling af pencilliner og cephalospoiner
DK439077A (da) 1-aryloxy-2-hydroxy-3-alkylenaminopropaner og fremgangsmaade til fremstilling deraf
DK557876A (da) Polyhalogensteroider og fremgangsmade til deres fremstilling
NO152975C (no) Glyceroloksydase og fremgangsmaate til fremstilling derav.
DK275178A (da) Fremgangsmaade til fremstilling af lipopeptider og anvendelse deraf
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
DK243176A (da) Fremgangsmade til fremstilling af polycliske forbindelser
DK398375A (da) N-acylamino-alfa-arylacetamidocephalosporiner og fremgangsmade til fremstilling heraf
DK222975A (da) Fremgangsmade til fremstilling af polysocyanater og disses anvendelse
DK539677A (da) Vaadvlies og fremgangsmaade til fremstilling deraf
DK401575A (da) Cis-decahydroisoquinolin-analgetika og fremgangsmade til deres fremstilling
NO821849L (no) 4-halogen-dihydropyran-forbindelse og fremgangsmaate for fremstilling derav
DK411275A (da) Thiophensacchariner og fremgangsmade til fremstilling deraf
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK427876A (da) N-substituerede arylacetamider og fremgangsmade til fremstilling deraf
DK121776A (da) Fremgangsmade til fremstilling af tricosen-(9) og heneicosen-(9)
DK531276A (da) Alfa aminoketonderivater og fremgangsmade til fremstilling afsamme
DK544075A (da) S-triazin-forpolymerisater og fremgangsmade til deres fremstilling
DK509276A (da) Ramme for fotografier og lignende
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid